Request Discount

RNAi Technology Market (Therapeutics - Oncology, Hepatitis B and C, Neurological Disorders, Autoimmune Hepatitis, and Others Therapeutics): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0550

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the RNAi Technology Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the RNAi Technology Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of RNAi Technology Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on RNAi technology market provides in-depth analysis of segments and sub-segments in the global as well as regional RNAi technology market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional RNAi technology market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global RNAi technology market. According to the report, the global RNAi technology market is projected to grow at a CAGR of 19.8% over the forecast period of 2019-2025.


Market Insight

The RNA interference (RNAi) is a biochemical process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. In RNAi technology, double-stranded RNA silences the gene expression. This is by inhibition of the translation process or by the degradation of mRNA. RNAi facilitates cellular defense from infections occurred by RNA viruses such as influenza virus and rhabdovirus. Transposons and viruses are the targets of RNAi technology. RNAi technology helps in regulating the development and maintenance of the genome. RNAi technology is used to extract cells that are resistant to infectious organisms. RNAi technology hits on the protein which causes the spread of the virus. There are in-vitro applications of RNAi technology in mammals for various diseases. RNAi technology is estimated to be an important factor in evolution due to its essential role in epigenetics.


The extensive use of RNAi technology in the treatment of viral diseases, neurodegenerative diseases and oncology, is driving the growth of RNAi technology market. Cancer, HIV, Parkinson’s disease, Respiratory syncytial virus, and Hepatitis are diseases treated by RNAi technology. According to WHO, in 2017, globally 940000 people died of HIV. Countries have a commitment to the eradication of diseases, this heading to the growth of RNAi technology in the market. Furthermore, investments from major pharmaceutical companies in the biotechnology industry are also driving the growth of the same. However, high cost in the application of RNAi technology in the production of therapeutics and drug discoveries is likely to hamper the growth of this market. The increase in growth of RNAi technology in therapeutics, drug discovery, development and agriculture can provide growth opportunities to the RNAi technology market.


Amongst the geographies, North America dominates the market by holding a major share in the market of RNAi technology. Increasing instances of viral diseases and cancer are stimulating the growth of the market. Moreover, the growth of biotechnology industries has also increased in the past few years heading to the growth of the market in North America. Moreover, Europe holds the second largest share in the growth of the RNAi technology market. The Asia Pacific is the fastest growing region as there is rising disposable income in this region. Growing technological advances in this region boost the growth of RNAi technology market.

Global RNAi Technology Market


Segment Covered

The report on global RNAi technology market covers segments such as therapeutics. On the basis of therapeutics, the sub-markets include oncology, hepatitis b and c, neurological disorders, autoimmune hepatitis, and others therapeutics.


Companies Profiled:

The report provides profiles of the companies in the market such as Thermo Fisher Scientific, Silence Therapeutics, Merck & Co., Inc., Ionis Pharmaceuticals, Quark Pharmaceuticals, Dicerna Pharmaceuticals, Arcturus Therapeutics Ltd., and Alnylam Pharmaceuticals Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of RNAi technology market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount